rimantadine has been researched along with Necrotizing Enterocolitis in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Excerpt | Relevance | Reference |
---|---|---|
"To review the maternal and neonatal outcomes after antepartum exposure to M2 ion channel inhibitors or oseltamivir to provide some guidance on the risk, if any, of antiviral medication during pregnancy." | 3.76 | Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. ( Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greer, LG | 1 |
Sheffield, JS | 1 |
Rogers, VL | 1 |
Roberts, SW | 1 |
McIntire, DD | 1 |
Wendel, GD | 1 |
1 other study available for rimantadine and Necrotizing Enterocolitis
Article | Year |
---|---|
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza | 2010 |